At the 2021 Fall Clinical Dermatology Conference, held virtually and from Las Vegas, pharmaceutical company Leo Pharma presented data from a new trial of its antibody treatment tralokinumab, sold under the brand name Adtralza, which is approved in the EU, the UK and Canada as a treatment for adults with moderate-to-severe atopic dermatitis.
The new results come from the phase III trial Ecztra 6, which has investigated the treatment in the younger segment of patients aged 12 to 17. The participants have received Adtralza over 16 weeks in one of two dosages, or a placebo substance.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Former Ambu CEO's equity investments end in USD 2m losses
Juan Jose Gonzalez, who was the CEO of medtech firm Ambu until very recently, has lost just over DKK 16m (USD 2.3m) before taxes on his share purchases.
Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
ALK finds replacement for long-time North America lead
Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.
Monkeypox vaccine attracts interest for Bavarian as virus spreads
Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
Almirall announces Danish launch of MC2 Therapeutics-developed psoriasis cream
Almirall is launching psoriasis cream Wynzora in Denmark. The treatment has been inlicensed from Danish firm MC2 Therapeutics, where the CEO says ”it is a special feeling” to see Wynzora launched in its home country.
Director for innovative pre-clinical testing unit 
Procurement Manager, Direct Materials 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Project Manager & Scrum Master 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Consultant Manager 
Director Global Engineering 
Biomarker Operations Lead 
Quality System Manager 
(Senior) Drug Substance Specialist 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Nordic Medical Affairs Manager 
Client Talent Acquisition Specialist 
Key Account Manager, Europe and Asia 
Senior Manager, Clinical Trial Budget 
Innovation Project Manager, Display Unit